Vimarsana
Biggest News Aggregation in the World

Page 14 - Marksans Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marksans Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marksans Pharma Today - Breaking & Trending Today

Digestive Drugs Market to surpass US$ 82,969.4 Million by 2030, Says Coherent Market Insights (CMI) - Vimarsana News

Digestive Drugs Market to surpass US$ 82,969.4 Million by 2030, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global digestive drugs market is estimated to be valued at US$ 52,594.8 Million in 2022 and is expected to exhibit a

Marksans Pharma Ltd Q3FY23 consolidated net profit at Rs. 63.40 crores - Vimarsana News

Marksans Pharma Ltd Q3FY23 consolidated net profit at Rs. 63.40 crores

The Board of Directors of Marksans Pharma Limited have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23, 9MFY23 at its board meeting.

Nifty, Sensex under pressure - Weekly Closing Report - Vimarsana News

Nifty, Sensex under pressure - Weekly Closing Report

Major indices plunged this week as the crash in Adani Group shares spread across the board and the banking sector faced the most pressure.

Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution - Vimarsana News

Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution

Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

Nifty, Sensex Inch up on Better Corporate Results - Monday Closing Report - Vimarsana News

Nifty, Sensex Inch up on Better Corporate Results - Monday Closing Report

The market was up today as many large companies especially from the financial sector posted better results.